ArticlePeerJ2023

Head and neck squamous cell carcinoma-specific prognostic signature and drug sensitive subtypes based on programmed cell death-related genes.

Chengbo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.